The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of warrants and Director Dealing

28 Jul 2022 07:00

RNS Number : 0039U
Asimilar Group PLC
28 July 2022
 

Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulations ("MAR"). Upon publication of this Announcement, this information is now considered to be in the public domain.

 

28 July 2022

 

Asimilar Group plc

 

("Asimilar", the "Company" or the "Group")

 

 

Exercise of warrants and Director Dealing

 

The Board of Asimilar (AIM/AQSE: ASLR) has today received an exercise notice from Sohail Bhatti, a director of the Company, in respect of warrants ("Warrants") to subscribe for 2,000,000 new ordinary shares of 0.01 pence each in the Company ("Ordinary Shares"). The Warrants have an exercise price of 5 pence per share.

 

The instrument that created the Warrants provided for a "cashless exercise" mechanism, whereby a formula calculates the number of new Ordinary Shares to be issued to the holder of the Warrants for the payment of the nominal value per Ordinary Share. This is derived from the average mid-market closing price for an Ordinary Share over the preceding 30 calendar days and results in a number of new Ordinary Shares being issued to reflect the "in the money" value of the Warrants, without the holder being required to pay the full exercise price for all 2,000,000 Ordinary Shares. The number of new Ordinary Shares to be issued pursuant to this cashless exercise mechanism is 1,090,849.

 

Following the issue of the new Ordinary Shares, Mr Bhatti will have an interest in 1,157,516 Ordinary Shares, representing 0.94% of the Company's issued share capital.

 

Application has been made to AIM and AQSE for the admission to trading on those respective markets of these new Ordinary Shares. It is expected that admission will become effective on or around 2 August 2022.

 

Total Voting Rights

Following the issue of the new Ordinary Shares, the issued ordinary share capital of the Company will comprise 123,348,125 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 123,348,125. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The FCA notification in respect of the above, made in accordance with the requirements of the UK Market Abuse Regulation, is appended below. The Directors of the Company are responsible for the release of this announcement.

 

 

Contact details:

 

Asimilar Group plc

John Taylor

via Buchanan

 

 

Cairn Financial Advisers LLP (AIM Nominated Adviser)

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

 

 

Peterhouse Capital Limited (Joint Broker)

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Oberon Capital (Aquis Corporate Adviser and Joint Broker)

Chris Crawford

Tel + 44 20 3179 5300

 

 

Buchanan Communications Ltd

 

Tel: +44 20 7466 5000 or Asimilar@buchanan.uk.com

Richard Oldworth

Chris Lane

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sohail Bhatti

2

Reason for the notification

a)

Position/status

Director

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group plc

b)

LEI

213800AYJZ2B8QNY7H15

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument 

Identification code

Ordinary shares of 0.01p in Asimilar Group plc

GB00BFX2VL54

b)

Nature of the transaction

Exercise of warrants and issue of new ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.01p

 

1,090,849

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

N/A

e)

Date of the transaction

27 July 2022

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAAXXAASAEAA
Date   Source Headline
30th Apr 20149:30 amRNSDirectorate Change
14th Apr 20147:00 amRNSBusiness Update
9th Apr 20149:00 amRNSReplacement announcement: Director resignation
9th Apr 20147:00 amRNSDirector Resignation
12th Mar 20147:00 amRNSNew Contract Wins valued at more than £0.5m
5th Mar 20147:00 amRNSNotice of AGM
21st Feb 20147:00 amRNSFinal Results
10th Feb 201411:00 amRNSTrading Update & Notice of Results
17th Dec 20137:00 amRNSChange of UK Head Office & Registered Office
28th Nov 201311:00 amRNSTrading Statement
16th Aug 20137:00 amRNSAppointment of Director and Grant of Share Options
26th Jun 20137:01 amRNSAppointment of Broker
26th Jun 20137:00 amRNSHalf Yearly Report
24th Jun 20137:00 amRNSNew contract wins
15th May 20138:41 amRNSResignation of NED & Appointment of Head of Ops
23rd Apr 201312:37 pmRNSResult of AGM
19th Apr 20137:00 amRNSChange of Adviser
18th Apr 20137:00 amRNSStmnt re Share Price Movement
28th Mar 20137:00 amRNSFinal Results for the Year Ended 30 September 2012
26th Mar 20139:47 amRNSPentagon Protection signs distribution agreement
18th Mar 20137:00 amRNSLoan Agreement
21st Feb 20137:00 amRNSNew Contract Win Valued at £1.9m
22nd Jan 20137:00 amRNSNew contract wins
8th Nov 20127:00 amRNSTrading Update and Result of General Meeting
8th Oct 20127:00 amRNSNew Contract Gains
18th Sep 20127:00 amRNSFurther Contract Gains
3rd Jul 20127:00 amRNSFurther Contract Gains
27th Jun 20127:00 amRNSIssue of Equity and Capitalisation of Loan
7th Jun 20129:17 amRNSInterim Results
30th Apr 20127:00 amRNSFurther Contract Gains
17th Apr 201212:24 pmRNSTotal Voting Rights
16th Apr 20124:33 pmRNSResult of AGM
16th Apr 20127:00 amRNSPENTAGON ANNOUNCES CONTRACT GAINS ACROSS THE GROUP
11th Apr 20124:10 pmRNSRestriction on New Share Authorities
3rd Apr 20123:10 pmRNSAdjournment of AGM
8th Mar 20129:30 amRNSNotice of AGM and Share Capital Reorganisation
7th Mar 201210:38 amRNSFinal Results
17th Nov 20117:00 amRNSTrading Update
8th Sep 20117:00 amRNSContract Gains
9th Aug 20117:00 amRNSContract Awards
28th Jul 20117:00 amRNSNew Contract Win
30th Jun 20119:01 amRNSHalf Yearly Report
24th May 201111:26 amRNSNew Contract Win
28th Apr 20114:52 pmRNSContract Award and Resignation of Director
15th Apr 20115:09 pmRNSResult of AGM
18th Mar 201110:00 amRNSDoc re. Report and Accounts / Related Pty Tran
18th Mar 20119:52 amRNSFinal Results
24th Nov 201012:36 pmRNSAppointment of Director
12th Nov 20104:30 pmRNSResult of GM
26th Oct 20107:00 amRNSAcquisition & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.